Zykadia
Drug - Zykadia™ (ceritinib) [Novartis Pharmaceutical Corporation]
November 2014
Therapeutic Area - Antineoplastic
Approval criteria
- Patient must have a diagnosis of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) AND
- Patient has tried and failed Xalkori (crizotinib)
Questions?
MHCP Provider Call Center 651-431-2700 or 800-366-5411